Royalty Pharma plc

Headquarters: New York, NY, United States

CEO: Mr. Pablo Gerardo Legorreta


Market Cap

$16.64 Billion

USD as of Jan. 1, 2024

history Market Cap History

Royalty Pharma plc market capitalization over time

Evolution of Royalty Pharma plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Royalty Pharma plc

Detailed Description

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.


"Bulls make money...
Bears make money...
Pigs get slaughtered!"

Stop guessing, unlock Financial AI.

(Don't be a pig.)

Stocks & Indices

Royalty Pharma plc has the following listings and related stock indices.

Stock: NASDAQ: RPRX wb_incandescent

Stock: FSX: RPD wb_incandescent

Stock: Munich: RPD wb_incandescent



110 East 59th Street

Floor 33

New York, NY 10022

United States

Phone: 212-883-0200